Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-041580
Filing Date
2021-10-26
Accepted
2021-10-26 17:30:00
Documents
1
Period of Report
2021-10-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12824
  Complete submission text file 0000899243-21-041580.txt   14359
Mailing Address 101 SOUTH HANLEY ROAD, SUITE 1850 ST. LOUIS MO 63105
Business Address 101 SOUTH HANLEY ROAD, SUITE 1850 ST. LOUIS MO 63105 (314) 726-6700
RiverVest Venture Fund IV, L.P. (Reporting) CIK: 0001725443 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 211349758

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations